SMTL ID : 5h25.1 (1 other biounit)

EED in complex with PRC2 allosteric inhibitor compound 11

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.88 Å

Oligo State

hetero-1-1-mer

Ligands

1 x LQH: 5-(2-fluorophenyl)-2,3-dihydroimidazo[2,1-a]isoquinoline(Non-covalent)

LQH.1: 7 residues within 4Å: Chain A: F.23, N.72, Y.74, N.120, Y.291, R.293, R.340 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.23, A:F.23, A:F.23, A:F.23, A:Y.74, A:N.120, A:Y.291, A:Y.291, A:Y.291 pi-Stacking: A:Y.74 Halogen bonds: A:Y.74

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huang, Y. et al., Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy. J. Med. Chem. (2017)

Release Date

2017-01-25

Peptides

Polycomb protein EED: A
Histone-lysine N-methyltransferase EZH2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

Polycomb protein EED

Histone-lysine N-methyltransferase EZH2

Related Entries With Identical Sequence